Efficacy and safety of donafenib combined with PD-(L)1 inhibitors plus TACE for unresectable hepatocellular carcinoma patients.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Song Wang, Chunpeng Yu, Yinghao Meng, Jian Li, Qun Li, Zhenkang Qiu, Shuai Chang, Shuo Zhang
Institution: Affiliated Hospital of Qingdao University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410814574